Key Quantitative Details
- Number of shares approved: 1,00,000 equity shares
- Face value: ₹10 per share
- Issue premium: ₹229.50 per share
- Distinctive numbers: 27525581 to 27625580
- Total issue size: Approximately ₹2.395 crore (1,00,000 shares × ₹239.50 per share)
Dates and Timeline
- BSE approval letter date: 19th October, 2026
- Company disclosure date: 19th October, 2026
- The company must apply for trading approval within seven working days from the grant of listing approval
Parties Involved
- Issuing Company: Emkay Global Financial Services Limited
- Stock Exchanges: BSE Limited and National Stock Exchange of India Limited
- Allottee: Mr. Prakash Kacholia (Promoter of the Company)
- Depositories: NSDL and CDSL
- Company Officials: Nishant S. Shirke, Company Secretary and Compliance Officer
Next Steps and Compliance Requirements
The company must now:
1. Obtain listing approval from National Stock Exchange of India Limited (if applicable)
2. Submit confirmation letters from NSDL/CDSL about:
- Crediting of shares to beneficiary accounts
- Admission of capital to depository system
- Lock-in of pre-preferential holding (if applicable)
3. File for trading approval within seven working days from grant of listing approval
4. Comply with shareholding pattern filing requirements under Regulation 31(1)(c) of SEBI LODR Regulations for changes exceeding 2% of total paid-up capital
Financial and Capital Structure Impact
The issuance represents a capital infusion of approximately ₹2.395 crore through the conversion of warrants held by promoter Prakash Kacholia. The shares were issued at a significant premium of ₹229.50 over the face value of ₹10 per share.
#Tags: #EmkayGlobal #BSEListingApproval #SEBIDisclosure #PreferentialAllotment #RegulatoryCompliance #Neutral